The average P/S ratio for XRAY's competitors is 3.13, providing a benchmark for relative valuation. DENTSPLY SIRONA Inc Corp (XRAY) exhibits a P/S ratio of 0.90, which is -71.11% above the industry average. Given its robust revenue growth of -7.76%, this premium appears unsustainable.